GSK Shingles Vaccine Shingrix Gets First Okay in Canada

Share this post

Shingrix, given in two doses 2 to 6 months apart, is for adults aged 50 years and older. It was shown to achieve ≥90% efficacy in clinical trials.
International Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply